Insider · CIK 0001620152

Bazemore Robert B

Reports to the SEC for 6 companies · WALTHAM, MA

sec.gov

Transactions

Companies

Filings

CIK

0001620152

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-16	ARDXARDELYX, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+39.7K sh	—	—	39,715
2026-06-16	ARDXARDELYX, INC.A Award	Director	AAward	+26.5K sh	—	—	68,006
2026-05-21	NUVBNuvation Bio Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+123K sh	—	—	123,397
2025-12-16	AKTXAkari Therapeutics Plc · Warrants to purchase American Depositary Shares ("ADRs")P Purchase	Director	PPurchase	+124K sh	—	—	123,731
2025-12-16	AKTXAkari Therapeutics Plc · Pre-Funded Warrants to purchase ADRsP Purchase	Director	PPurchase	+124K sh	$0.40	+$50K	123,731
2025-12-16	AKTXAkari Therapeutics Plc · Warrants to purchase ADRsP Purchase	Director	PPurchase	+30.9K sh	—	—	30,932
2025-12-16	AKTXAkari Therapeutics Plc · Pre-Funded Warrants to purchase ADRsP Purchase	Director	PPurchase	+30.9K sh	$0.40	+$12.5K	30,932
2025-06-18	ARDXARDELYX, INC.A Award	Director	AAward	+41.6K sh	—	—	41,551
2025-06-18	ARDXARDELYX, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+54.1K sh	—	—	54,059
2025-05-21	NUVBNuvation Bio Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+293K sh	—	—	292,983
2025-03-20	AKTXAkari Therapeutics Plc · Stock Option (Right to Buy)A Award	Director	AAward	+225K sh	—	—	225,000
2025-03-20	AKTXAkari Therapeutics Plc · Stock Option (Right to Buy)A Award	Director	AAward	+175K sh	—	—	175,000
2025-03-06	AKTXAkari Therapeutics PlcA Award	Director	AAward	+44.6K sh	$1.12	+$50K	44,642
2025-03-06	AKTXAkari Therapeutics Plc · Series B Warrants (Right to Buy)A Award	Director	AAward	+44.6K sh	$1.12	+$50K	44,642
2025-03-06	AKTXAkari Therapeutics Plc · Series A Warrants (Right to Buy)A Award	Director	AAward	+44.6K sh	$1.12	+$50K	44,642
2024-09-17	AKTXAkari Therapeutics Plc · Stock Option (Right to Buy)A Award	Director	AAward	+5M sh	—	—	5,000,000
2024-09-03	NUVBNuvation Bio Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+201K sh	—	—	200,801
2024-06-14	ARDXARDELYX, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+40.2K sh	—	—	40,243
2023-06-15	ARDXARDELYX, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+49.2K sh	—	—	49,237
2023-05-15	NUVBNuvation Bio Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+367K sh	—	—	366,744
2022-06-15	ARDXARDELYX, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+100K sh	—	—	100,000
2022-05-16	NUVBNuvation Bio Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+119K sh	—	—	118,784
2022-05-16	NUVBNuvation Bio Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+141K sh	—	—	140,713
2021-10-29	NUVBNuvation Bio Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+45.2K sh	—	—	45,229
2021-06-16	ARDXARDELYX, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+32.8K sh	—	—	32,765
2021-03-30	NUVBNuvation Bio Inc.P Purchase	Director	PPurchase	+5,000 sh	$9.98	+$49.9K	5,000
2021-03-25	Epizyme, Inc.S Sale	Director, President & CEO	SSale	−10.3K sh	$7.85	−$81.1K	322,626
2021-02-10	NUVBNuvation Bio Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+188K sh	—	—	187,658
2021-02-10	NUVBNuvation Bio Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+51.7K sh	—	—	51,703
2021-02-04	Epizyme, Inc.S Sale	Director, President & CEO	SSale	−3,890 sh	$11.21	−$43.6K	331,977
2021-02-01	Epizyme, Inc.Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+417K sh	—	—	417,443
2021-02-01	Epizyme, Inc.A Award	Director, President & CEO	AAward	+87.5K sh	—	—	335,867
2021-01-25	Epizyme, Inc.S Sale	Director, President & CEO	SSale	−6,069 sh	$11.41	−$69.2K	248,367
2020-06-26	Epizyme, Inc.S Sale	Director, President & CEO	SSale	−4,773 sh	$16.15	−$77.1K	250,098
2020-06-25	Epizyme, Inc.A Award	Director, President & CEO	AAward	+10.5K sh	—	—	254,871
2020-06-18	Epizyme, Inc.S Sale	Director, President & CEO	SSale	−10K sh	$22.00	−$220K	244,371
2020-06-18	Epizyme, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	−10K sh	—	—	323,333
2020-06-18	Epizyme, Inc.M Exercise/Conversion	Director, President & CEO	MExercise/Conversion	+10K sh	$8.98	+$89.8K	264,371
2020-06-18	Epizyme, Inc.S Sale	Director, President & CEO	SSale	−10K sh	$22.00	−$220K	254,371
2020-06-09	ARDXARDELYX, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+23.5K sh	—	—	23,500
2020-05-06	Neon Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−28K sh	—	—	0
2020-05-06	Neon Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−18.5K sh	—	—	0
2020-03-25	Epizyme, Inc.S Sale	Director, President & CEO	SSale	−3,285 sh	$15.28	−$50.2K	254,371
2020-03-24	Epizyme, Inc.A Award	Director, President & CEO	AAward	+7,000 sh	—	—	257,656
2020-03-24	Epizyme, Inc.J Other	Director, President & CEO	JOther	−56.5K sh	—	—	80,726
2020-03-24	Epizyme, Inc.Stock Option (Right to Buy)A Award	Director, President & CEO	AAward	+73.4K sh	—	—	73,409
2020-03-24	Epizyme, Inc.Stock Option (Right to Buy)J Other	Director, President & CEO	JOther	−48.7K sh	—	—	298,737
2020-03-24	Epizyme, Inc.Stock Option (Right to Buy)J Other	Director, President & CEO	JOther	−2,371 sh	—	—	333,333
2020-03-24	Epizyme, Inc.Stock Option (Right to Buy)J Other	Director, President & CEO	JOther	−79.2K sh	—	—	333,333
2020-03-24	Epizyme, Inc.A Award	Director, President & CEO	AAward	+113K sh	—	—	250,656

Recent filings

Accepted (ET)
Jun 184
Bazemore Robert B0001620152-26-000005
SEC(opens sec.gov)
May 264
Bazemore Robert B0001620152-26-000003
SEC(opens sec.gov)
Dec 184
Bazemore Robert B0001493152-25-028416
SEC(opens sec.gov)
Jun 234
Bazemore Robert B0001628280-25-032730
SEC(opens sec.gov)
May 234
Bazemore Robert B0001415889-25-014416
SEC(opens sec.gov)
Mar 244
Bazemore Robert B0000950170-25-043939
SEC(opens sec.gov)
Mar 104
Bazemore Robert B0000950170-25-036482
SEC(opens sec.gov)
Sep 184
Bazemore Robert B0000950170-24-107828
SEC(opens sec.gov)
Sep 54
Bazemore Robert B0001415889-24-022965
SEC(opens sec.gov)
Jun 174
Bazemore Robert B0001628280-24-028596
SEC(opens sec.gov)
Jun 164
Bazemore Robert B0001628280-23-022552
SEC(opens sec.gov)
May 174
Bazemore Robert B0001209191-23-030259
SEC(opens sec.gov)

Companies

Address

C/O ARDELYX, INC. 400 FIFTH AVENUE, SUITE 210

WALTHAM, MA, 02451